Next Article in Journal
Sensors: Views of Staff of a Disability Service Organization
Previous Article in Journal
Structured Decision-Making: Using Personalized Medicine to Improve the Value of Cancer Care
Open AccessOpinion

Driving Forces Behind the Past and Future Emergence of Personalized Medicine

1
Imperial College London, Exhibition Road, London SW7 2AZ, UK
2
Christian-Albrechts-University Kiel, Christian-Albrechts-Platz 4, 24118 Kiel, Germany
*
Author to whom correspondence should be addressed.
J. Pers. Med. 2013, 3(1), 14-22; https://doi.org/10.3390/jpm3010014
Received: 23 November 2012 / Revised: 14 January 2013 / Accepted: 14 January 2013 / Published: 17 January 2013
Personalized medicine can be seen as a continuously developing approach to tailoring treatments according to the individual characteristics of a patient. In some way, medicine has always been personalized. During the last decade, however, scientific and technological progress have made truly personalized healthcare increasingly become reality. Today’s personalized medicine involves targeted therapies and diagnostic tests. The development of targeted agents represents a major investment opportunity to pharmaceutical companies, which have been facing the need to diversify their business due to an increasingly challenging market place. By investing into the development of personalized therapies, pharmaceutical companies mitigate a major part of the risks posed by factors such as patent expiries or generic competition. Viewing upon personalized medicine from different perspectives points out the multi-causality of its emergence. Research efforts and business diversification have been two main driving forces; they do supplement each other, however, are not jointly exhaustive in explaining the emergence of this approach. Especially in the future, a number of further stakeholders will impact the evolution of personalized medicine. View Full-Text
Keywords: personalized healthcare; diagnostic testing; genomic medicine; business diversification personalized healthcare; diagnostic testing; genomic medicine; business diversification
Show Figures

Figure 1

MDPI and ACS Style

Steffen, J.A.; Steffen, J.S. Driving Forces Behind the Past and Future Emergence of Personalized Medicine. J. Pers. Med. 2013, 3, 14-22.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop